Season’s greetings from all of us at the European Cancer Organisation and the European Cancer Community Foundation!
This holiday season, we extend our heartfelt gratitude to everyone in our vast cancer community. Thank you for your unrelenting dedication and hard work in accelerating cancer care across Europe. Your efforts inspire us every day.
Read more
Receiving a cancer diagnosis is a life-altering moment. For patients, the period between diagnosis and the start of treatment often becomes an agonising wait, amplifying feelings of anxiety, helplessness, and emotional distress. The consequences of delayed treatment can be particularly severe for certain types of cancer, where even a delay of a few weeks can greatly impact treatment outcomes.
Cancer patients should be protected from the psychological and physical effects of delayed treatment. Our health systems must become more efficient to ensure all patients receive timely quality care.
Read moreThe smartCARE project proudly announces the launch of its Cancer Survivor Smart Card prototype, a groundbreaking digital tool designed to empower individuals living with and beyond cancer. This milestone event, held in Brussels on 22 November 2024 represents a significant advancement in the smartCARE initiative, co-funded by the European Union under the EU4Health Programme (2021–2027).
Read moreCancer screening is a key element in the fight against cancer. Implementing best screening practices is critical to detect the disease early and increase chances of survival.
Read more
The crisis within Europe’s health and cancer workforce requires urgent attention. Recent events, such as the Covid-19 pandemic, continue to take a huge toll on healthcare professionals, and the growing shortages within the cancer workforce are having a profound impact on the dedicated workers on the frontlines of cancer care.
This is why the European Cancer Organisation, under the leadership of its Workforce Network and supporting partners, launched Time to Accelerate for our Workforce, an extensive public awareness campaign to address this pressing issue.
At today's European Cancer Summit, the latest element of this campaign is being unveiled: the results of an extensive Pan-European survey of more than 700 cancer professionals from 30 countries – together with many of their personal stories.
Read more
Research suggests that 45% of LGBTIQ individuals in the EU experience difficulties accessing healthcare, with trans women, men, and intersex persons being disproportionately affected (EU FRA, LGBTIQ at a crossroads, 2024). Inadequate training, non-inclusive policies, and the absence of safe spaces compound these challenges.
Against this backdrop, the European Cancer Organisation during the European Cancer Summit launched a new pan-European citizen and patient survey, addressing disparities faced by LGBTIQ individuals in cancer screening and care.
Read more
Today, the European Cancer Organisation held its General Assembly, where its Member Societies elected Isabel Rubio as the President-Elect of the European Cancer Organisation.
Read more
Europe has exciting opportunities for improving cancer care and patient outcomes within its grasp. Yet these are not fully utilised currently with policy obstacles for their adoption still to be addressed. So concludes a new Policy Action report of the European Cancer Organisation: ‘Unlocking Potential: New Treatment Paradigms in European Cancer Care’.
Read more